Knee osteoarthritis (OA) is common and is one of the five leading causes of disability in Singapore; it entails significant cost to society. Singapore is one of the faster ageing populations in Asia and obesity is on the rise. The public health consequences of OA, particularly knee OA are therefore expected to rise dramatically. There is thus an urgent need for advancement in research in this area. An accurate estimate of the prevalence of knee OA would improve the understanding of its impact in different sectors of society, and facilitate public health decision-making and resource allocation to address this upcoming challenge in public health. Currently there is no proven drug that slows down the osteoarthritis process and management of knee OA is symptomatic. Identification of genetic, environmental, inflammatory and biomechanical risk factors will help us to understand the pathogenesis and find factors for its prevention. There is a need for early diagnosis of knee OA and identifying subjects who are more likely to benefit from drug treatment. Effort is needed in the discovery of drugs that have disease modifying effect to treat this disabling disease. Understanding the biomechanical factors underlying knee OA may also lead to the discovery of new recommendation and treatment strategies.
INtRODUctION
Osteoarthritis (OA) is the most common type of joint disease and its high prevalence entails significant cost to society. The World Health Organisation (WHO) estimates that 9.6% of men and 18% of women aged ≥60 years have symptomatic OA worldwide 1 . OA of the knee is a major cause of impaired mobility, particularly among women and is one of the five leading causes of disability among non-institutionalised adults. More than 80% of patients with knee OA have some degree of movement limitation, and 25% cannot perform major activities of daily living, 11% need help with personal care and 14% require help with routine needs 2 . The cost of OA to society is impressive, estimated at US$15.5 billion (in 1994 dollars), roughly three times the cost of rheumatoid arthritis. More than half of the OA costs are due to work loss 3 .
tHE PERSPEctIVE OF tHE OA bURDEN
The burden of OA knee is expected to accelerate in the coming decades. Risk factors for knee OA have been studied mostly in Caucasian populations residing in high-income countries. These include age, female gender, obesity, a history of knee surgery or significant trauma, and having an occupation requiring heavy lifting, kneeling or squatting 4 . As the populations of developed nations age over the coming decades and the prevalence of obesity grows, the prevalence and burden of OA is expected to accelerate. Due to obesity together with symptomatic knee OA, Americans over the age of 50 will together lose the equivalent of 86 million healthy years of life as estimated from census data source 5 . Singapore is one of the fastest ageing populations in Asia. The population above 65 years rose from 7.2% in 2000 to 9% in 2010 and is predicted to be 19% by 2030, which translates to 235,000 elderly in 2000 and 796,000 elderly in 2030 6 . Obesity is on the rise from 6.9% in 2004 to 10.8% in 2010 and appears to be related to sedentary lifestyles and eating habits 7 . The high prevalence of OA entails significant costs to society. Costs associated with OA can be particularly significant for elderly persons, who face potential loss of independence and who may need help with daily living activities. Given the low prevalence of hip OA in Asian countries, knee OA Review Proceedings of Singapore Healthcare  Volume 22  Number 1  2013 would be the main problem 8, 9 . The objective of this article is to review the current research of knee OA in Singapore. Several research gaps are identified and possible research directions are proposed.
MEtHODS AND SEARcH RESULtS
We performed a literature search on Ovid Medline and Pubmed from January 1992 to October 2012, using keywords "knee osteoarthritis" and "Singapore or Asia". We included original articles of all study designs including epidemiology studies, cohort studies, observational studies, and controlled trials. We excluded non-human and in-vitro studies, case reports, review articles, articles with main focuses on outcome of "knee replacement surgeries", "surgical techniques" and "evaluation or validation of outcome instruments". Of 57 articles retrieved that were from Singapore or Asia, we included six articles [10] [11] [12] [13] [14] [15] . A further two articles were identified from references of included articles 16, 17 and one from the Singapore National Health Survey 18 . These articles were discussed under the research gaps identified. There were six, three, two, and seven articles excluded due to non-human studies, case reports, reviews, and irrelevance. Twenty-one and 12 articles were excluded for their main focuses being surgical outcomes or surgical techniques and evaluation of outcome instruments.
WHAt IS KNOWN AbOUt tHE bURDEN OF OA KNEE IN SINGAPORE?
Prevalence estimates are essential for the evaluation of the costs of knee OA and the healthcare needs generated. This knowledge is crucial to plan and optimise health resource allocation. There is a paucity of epidemiological research in OA knee in the Asian region. The prevalence of OA or knee OA in Singapore is unknown. A population survey in Singapore in 1991 revealed that arthritis and rheumatism was very common, in up to 25% in different ethnic groups. A sizable proportion of this may be related to OA 16 . From the 2007 National Health Survey, the crude prevalence of self-reported arthritis was 10%. Prevalence of joint symptoms was higher among females, Indians and those of advancing age. The prevalence was up to 19.8% among the 60-69 age groups 18 . In the 2004 Singapore Burden of Disease Study, OA was the fifth highest cause of disability-adjusted life years (DALY) in the older age group 17 . The data on OA in this study was based on the best available data, as accurate information on the prevalence of OA in Singapore is not available.
While it is reasonable to extrapolate some of the prevalence data and risk factor findings from Caucasian countries, there are also likely to be significant demographic and environmental differences that influence the onset and progression of OA in these regions. In the 1990s, the WHO initiated the Community Oriented Program for Control Of Rheumatic Disorders (COPCORD) in developing countries. From the COPCORD studies, the prevalence of knee pain is high among Asian countries. However in most studies, plain radiography (X-ray) was used as case definition and this limits the application in epidemiology studies. The cause of knee pain is not evaluated and prevalence estimates for OA knee is rarely available 8, 9, 19 . These limit the evaluation of the impact of knee OA in the population.
In Singapore, there is no prevalence data on knee OA. However in hospital settings, the direct and indirect costs for patients with advanced hip and knee OA are as high as that in Western countries 20 . Direct costs of OA include clinician visits, medications, and surgical interventions. Indirect cost refers to the productivity loss incurred due to the illness, such as time lost from work or time lost from work from the patient's caregiver. Intangible costs are defined as pain and suffering of patients because of a disease, which are usually measured using the reduction in quality of life. The direct cost to patients (calculated as mean costs per patient per annum in 2003) ranged from SGD 1,320 to SGD 12,140; direct cost to society ranged from SGD 2,939 to SGD 17,879. There was a threefold increase in economic burden of OA to society and patients for those with end-stage disease who required joint replacement surgery 10 . This direct cost is even higher than that of most Western countries 20 and similar to that in Hong Kong 14 . Indirect cost for OA was substantial and accounted for 2.8% of average household income as calculated with the average earnings per capita per day in Singapore between 1993 and 2003 21 . In the same study, the intangible cost incurred by OA was also high, accounting for 3.3% of the average household income. It is well known that costs of illness may vary from country to country, given their different health systems and the methodology in cost evaluation 22 . The burden of illness of knee and hip OA in terms of pain and disability could also be influenced by ethnicities, socioeconomic status and psychosocial factors 23 . Despite these differences, Proceedings of Singapore Healthcare  Volume 22  Number 1  2013 the economic burden incurred by OA in Singapore is substantial.
There are ways to reduce the burden of this disabling disease by early diagnosis and implementation of effective evidence-based strategies such as large-scale community based self-management education, advocating weight management and exercise programmes, preventing joint injuries and more focused research in this area 24, 25 . All of these involve relocation of health care resources, which is based on an accurate prevalence estimation followed by careful evaluation of the impact of knee OA in larger groups of subjects in the population.
tHE PREVALENcE OF OA IN SINGAPORE
Careful estimates of OA prevalence would improve the understanding of healthcare needs and would facilitate public health decision-making and resources allocation. Self-administered questionnaires on OA symptoms alone have shown inadequate sensitivity and specificity for OA screening 26 . Newer studies using questionnaires that combine symptoms, disability, and selfreported diagnosis have proven validity in screening symptomatic OA [27] [28] [29] . A study to evaluate and validate instruments that may be suitable for purpose of screening symptomatic OA knee in the population against the American College of Rheumatology (ACR) classification criteria for OA knee is currently underway in the Singapore General Hospital (SGH). If successful, it will provide an accurate prevalence estimate of symptomatic OA knee in Singapore when applied in epidemiological studies. It could also be a valuable instrument to reveal the impact of symptomatic OA knee in the general population. The next step would be to determine the prevalence and impact of OA in different sectors of society such as among the elderly and in the work place.
RISK FActOR IDENtIFIcAtION
Currently, there is no cure for OA. A balanced diet with supplementing 'nutraceuticals' has therefore been proposed for the prevention of OA development and progression 30 . On the molecular level, catabolism and oxidative stress within the chondrocytes, cartilage matrix, synovium and synovial fluid can promote cartilage degradation [31] [32] [33] . However, prospective data from observational studies conducting a comprehensive evaluation, including diet, lifestyle and genetic factors, as well as gene-environment interaction, on the etiologic association with severe knee OA are scarce 31, 34 . Asian populations have different dietary and lifestyle factors, and are rarely studied compared to Western populations. A collaborative team from SGH and Duke-National University of Singapore has initiated a cohort study in 2012 based on the database from the Singapore Chinese Health study (SCHS). The SCHS is a NIH supported large-scale research study on 63,257 Chinese subjects since 1993. A link has been established with the Ministry of Health database to identify cases that had undergone knee joint replacement surgery (TKR) for OA. These cases should represent those who had the most severe form of knee OA. Dietary, lifestyle, inflammatory and genetic factors will be analysed and compared with controls who reported no knee problem repeatedly. This will be the first longitudinal study on the etiology of severe OA of the knee from an Asian population, which will provide additional, novel and informative data to the current literature on knee OA.
tHE cHALLENGES OF DMOAD DEVELOPMENt
Given the limited effective and safe therapeutic options, current treatment of OA is palliative. An appreciable percentage of patients with OA knees are refractory to existing analgesics 35, 36 ; and a significant proportion of patients still experience pain, functional disability, poor quality of life and dissatisfaction even after the definitive treatment -TKR 37 . Advances in tissue engineering techniques have taken various types of stem cells and chondrocytes implantation to early phase clinical trials in human and may benefit a younger group of selected subjects with knee OA. The National University of Singapore has been pioneering research in this area 38 ; however cost-effectiveness has yet to be evaluated [39] [40] [41] . Another strategy is to modify the progression of structural damage. Given the large patient population and unmet medical need, the discovery and development of diseasemodifying OA drugs (DMOADs) have become a focus of drug development in the past decade. A variety of target agents are in mature phases of development. Some agents like glucosamine sulphate, chondriotin sulphate, diacerin, doxycycline, licofelone, strontium and intra-articular hyaluronans have demonstrated structural modifying ability in isolated clinical trials 42 , although none have convincingly demonstrated disease-modifying efficacy with concurrent clinically meaningful effects; and none was approved by the regulatory arbitrators. Challenges are faced in the process of DMOADs development and there are numerous negative reports in the literature 42, 43 . Overall, these trials mostly reported significant side-effect profile, no concomitant symptomatic relief and the radiographic methodology was criticised for deficient standardisation and inadequate positioning of the joint. Studies using joint-space narrowing (JSN) on X-ray as a structural modifying end-point were thought to be insensitive and inadequate to show up the changes in structure.
EARLY DIAGNOSIS OF OA
Traditionally structural assessment and diagnosis of OA has relied upon plain X-rays, which identify patients with late stage disease when structural damage may be irreversible. There is a need for new tools that foster early diagnosis of OA, particularly in the pre-radiological phase. Modern imaging technology like MRI has great potential in bridging this gap, once the validation and qualification process is optimised 44, 45 . However MRI is costly to perform and the scoring is labour intensive. Biomarkers are thus a promising modality to address this need, as they are relatively inexpensive and easy to perform in comparison with MRI. A combination of multiple biomarkers have been shown to improve the detection and prediction of radiographic changes in OA [45] [46] [47] . A study on the predictive values of a combination of biomarkers of cartilage metabolism, inflammation and genes to predict MRI outcomes in 120 subjects with knee pain is initiating in SGH. The project will inform on the possibility of using biomarkers, which is more cost-effective in the early diagnosis of OA. It would be a paradigm shifting discovery that paves the way for clinical trial in patients with early (preradiographic) OA where they would have a higher chance of responding to treatment.
tHE ROLE OF INFLAMMAtION, INNAtE IMMUNItY AND DMOAD DIScOVERY
There is cumulative evidence that inflammation play a major role in the pathogenesis of OA. Agents targeting specific inflammatory pathways potentially can reduce the inflammatory load and may slow down the structural damage. Colchicine, an agent used for the treatment of gout has the potential as a DMOAD. In a knee OA cohort with no clinical evidence or self-report of gout, a significant correlation of synovial fluid uric acid with radiographic and scintigraphic measures of OA severity was found 48 . There were also strong correlations between radiographic and scintigraphic severity and synovial fluid uric acid with synovial fluid IL-18 and IL-1β, two cytokines classically produced by uric acid-activated inflammasomes in gout. These results strongly support the potential involvement of the innate immune system in OA pathology and progression, just as for gout. The pain and symptom relieving effects of colchicine for knee OA have been demonstrated in three small but well-performed human randomised double-blinded placebocontrolled clinical trials (RCT)s [49] [50] [51] . One study in 36 subjects with knee OA demonstrated greater symptomatic improvement at 20 weeks with colchicine than placebo despite background therapy with nimesulide (30% WOMAC response rate 57.9% versus 23.5%) 50 . Another study of 61 knee OA subjects exhibited greater improvement in patient and physician global assessment at the end of three months treatment of colchicine versus placebo in addition to usual treatment (analgesics, NSAIDs and physiotherapy) (11.14 +/-4.06 vs 3.14 +/-2.18, P <0.001; and 9.83 +/-3.799 vs 3.72 +/-3.35, P <0.001, respectively) 51 .
In collaboration with Duke University Durham, we have proposed a randomised placebo-controlled trial (RCT) in Singapore to determine whether oral colchicine at standard clinical doses (0.5 mg, two times daily), compared to placebo, may decrease the pain of symptomatic OA knee and improve function when used as adjunctive daily therapy in addition to background therapy with the patient's current stable analgesic regimen. We will also evaluate the mechanism of action of colchicine for reducing knee OA signs and symptoms through analyses of synovial fluid, serum, and urine biomarker profiles -these will interrogate and characterise the state of activation of joint metabolism (joint degradation and synthesis markers), inflammatory mediators and the innate immune system specifically both before and after 16 weeks of therapy. The structure modifying effect will be evaluated in a proportion of subjects with knee MRI. This study is well grounded in a strong biological rationale; and with the several small preceding human studies of colchicine for knee OA provide a strong clinical rationale. This study will break new ground by exploring the mechanism of action of colchicine in knee OA through stringent testing of the ability of colchicine to inhibit inflammasome activation in OA. This trial can serve as a valuable paradigm Proceedings of Singapore Healthcare  Volume 22  Number 1  2013 for a subsequent larger longer-term multi-centred RCT to evaluate colchicine as a DMOAD for knee OA with long-term radiographic and MRI end-points to evaluate the ability of colchicine to slow or halt the progression of OA structural deterioration. With the increased understanding of the pathogenesis of OA at the molecular and cellular level, it is hoped that disease-modifying rather than just symptommodifying therapies will become a reality for this devastating condition.
bIOMEcHANIcAL FActORS IN OA Knee OA is not merely a condition characterised by cartilage degradation and inflammation, but it is also a mechanical joint failure driven by abnormal joint loading [52] [53] [54] [55] [56] . Hence, it is important to prevent or to reduce the abnormal intra-articular forces that are causing joint damage in the first place. Biomechanical factors that cause excessive knee loading and may influence the onset of knee OA are obesity 57, 58 , knee malalignment 59, 60 , knee joint laxity 61 , knee range-of-motion limitations 62, 63 , hip and knee muscle weakness [64] [65] [66] [67] [68] , and proprioceptive and postural control (balance) impairments 12, [69] [70] [71] . These factors are also closely associated with pain and functional disabilities 12, 13, 60, 69, 72, 73 . Among them, muscle and balance impairment are potentially modifiable.
As regards muscle impairments, the hip and knee musculature play an important role in minimising knee joint loading [64] [65] [66] [67] and protect the knee joint from micro-damage via an active absorbing mechanism 74 . For this reason, novel interventions that can safely and effectively overload both the hip and knee musculature are needed to slow disease progression and better yet, to improve pain relief and physical function. Eccentric resistance trainingvia eccentric ergometryis one such intervention that is currently under-explored in knee OA research but worthy of consideration given its potential ability to induce muscle hypertrophy and strength gains at a lower metabolic cost than does concentric training in both older adults and clinical populations 23, [75] [76] [77] . A randomised study on the effectiveness of eccentric ergometry in improving muscle performance and physical function in patients with mild-to-moderate symptomatic knee OA is currently underway in SGH.
As regards balance impairments, compared with people without knee OA, those with knee OA have impaired standing balance 78-81commonly defined as greater postural body sway or centre of pressure (CoP) displacementand more important, balance impairments were associated with increased fall risk 82, 83 . The estimated prevalence of falls in older adults was 22% for radiographic knee OA 84 , 48% for knee pain 84 and 48% in symptomatic end-stage knee OA 85 . Fall prevalence remained high at 24-40% even after TKR 85 . In prospective population studies, patients with TKR or clinically-diagnosed knee OA were found to have a paradoxical high risk of hip fracture 86, 87 . What factors perpetuateor reciprocally relate tobalance impairments and disability in knee OA? Apart from the biomechanical factors described earlier, psychological factors -for example, fear of falling 88, 96 , pain catastrophising 89 , depression 89, 90 and fear-induced activity limitation 13, 92 are also important correlates. Of interest, fear induced activity limitation (FIAL), which is the avoidance or curtailment of daily activities due to an excessive fear of falling, may lead to a vicious cycle of physical deconditioning, which in turn, perpetuates or increases the fear of falling and the fall risk. The SGH physiotherapy team found that in a sample of 72 patients one-year post-TKR, FIAL is common with a frequency of two of five patients (41% [31 patients]; 95% CI, 31% to 55%) 13 . These data highlight that FIAL is a common, but underreported problem in knee OA and suggest that early, preventive interventions are needed to improve physical function and to reduce fall risk in patients with FIAL. Due to the complex and multi-dimensional nature of falls and disability in knee OA, there is a paucity of well-accepted and validated falls screening tools available in the community setting 93 . Although CoP-based balance measures have prognostic and predictive relevance for fall 82 and fear of falling 96 , they are not commonly measured. The existing measuring equipment and methods are expensive, difficult to set-up, and thus not practicable to be used in large patient cohorts. To overcome the logistical and technical difficulties of assessing postural control in large patient samples, the SGH physiotherapists, together with sports biomechanists from the University of Melbourne, has created a programme to interface with the Wii Balance Board (WBB) (Nintendo, Kyoto, Japan). This is a portable (~3.5kg) low-cost (~130 SGD) gaming device that could be repurposed to measure CoP-based standing balance. These WBBderived standing CoP measures have demonstrated good concurrent validity with data obtained from a laboratory-grade forceplate 97 . The predictive validity has also been demonstrated in two Review Proceedings of Singapore Healthcare  Volume 22  Number 1  2013 prospective studies 98 . These served as a proof-ofconcept for this balance protocol to be developed as a valuable tool in balance assessments in different clinical settings.
FUtURE PERSPEctIVE
Osteoarthritis is a growing public health issue. Collaborative efforts from primary healthcare providers, secondary healthcare services, allied health and varies sector of the communities are necessary to help reduce the burden in the next few decades. The American Centre of Disease Control and Prevention (CDD) and the Arthritis Foundation have published their agenda to combat osteoarthritis 24 . No such initiative has been established in Singapore. An important consideration is to ensure current evidence-based intervention strategies, including self-management education, physical activity, injury prevention, and weight management and healthy nutrition are delivered to those who have OA. This also involves establishing supportive policies, communication initiatives and strategic alliances for OA prevention and management. Low impact, moderate intensity aerobic physical activity, muscle strengthening exercise and weight management should be promoted widely as a public health intervention and prevention for OA. National nutrition and dietary guidelines for the general population and even legislation to prevent over-consumption of fat and unhealthy ingredients in the public could be considered. Research and evaluation should be pursued to enhance surveillance, better understand risk factors, refine recommended intervention strategies, evaluate workplace interventions, and examine emerging evidence on additional promising pharmacological or nonpharmacological interventions. It is sad to note that less than 1% of the total expenditure on OA is presently spent on research.
In Singapore, there is an urgent need for more accurate prevalence estimation of OA in society and to determine the impact on the level of the individual and society. This will help policy makers plan and optimise health resource allocation. Prospective or population-based studies are required to improve our knowledge of risk factors for the development and progression of knee OA. The clinical and biological predictors of response to both pharmacological and non-pharmacological treatment for OA knee need to be determined. The efficiency and cost-effectiveness of various exercise programmes and how to implement at the public level need to be evaluated. There is growing knowledge about the cell biology and biochemistry of the cartilage that could give rise to new treatment possibilities in the future. Biochemical markers and new imaging techniques may identify people at risk or in earlier stages of the disease and allow for an early intervention in the near future and hasten up the discovery of DMARDs. Besides, understanding of the biomechanical factors that are associated with OA, like joint alignment, posture and balance, may lead to new treatment development.
cONcLUSION Knee OA is prevalent, disabling, incurring high cost to affected individuals and society. The prevalence is expected to rise due to the ageing population and the increasing prevalence of obesity. There has been a paradigm shift in the concept of OA from a purely degenerative process to a dynamic process involving inflammation, proper healing associated with joint loading before the end-stage process of cartilage degradation and eventually joint failure. The concept and understanding of the pathophysiology of OA is still evolving. Given the burden of disease from knee OA, there is a dearth of research in this area, particularly in Asia. Many areas of OA are ripe for research, for instance, to determine the burden of knee OA, to identify risk factors for progression, to identifying a model that diagnoses OA early when it is relatively treatable, the discovery of DMOADs, and the evaluation of biomechanical factors and their assessment in knee OA. Very few investigators are actively researching OA, because the old concept of it being a boring age-related, degenerative disease persists. We hope to encourage the next generation of clinicians and scientists to take up this exciting challenge of OA.
